Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?

Cover Page

Cite item

Full Text

Abstract

In September 2021, the European Society of Cardiology issued new guidelines on the management of patients with heart failure (HF). In the current version, experts have focused on the 4 most common variants: acute HF decompensation, acute pulmonary edema, cardiogenic shock, and isolated right ventricular failure. There has been a change in approaches to the initial management of patients with acute HF decompensation towards a decrease in the evidence-based use of peripheral vasodilators and a "return" to loop diuretics as the basis of treatment. This raises the question of monitoring the efficacy of diuretic therapy. The paper presents an algorithm proposed by the European Society of Cardiology.

About the authors

Igor V. Zhirov

Chazov National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

Author for correspondence.
Email: izhirov@mail.ru
ORCID iD: 0000-0002-4066-2661

D. Sci. (Med.), Chazov National Medical Research Center of Cardiology, Russian Medical Academy of Continuous Professional Education

Russian Federation, Moscow; Moscow

Svetlana N. Nasonova

Chazov National Medical Research Center of Cardiology

Email: dr.nasonova@mail.ru
ORCID iD: 0000-0002-0920-7417

Cand. Sci. (Med.), Chazov National Medical Research Center of Cardiology

Russian Federation, Moscow

Ulia A. Khalilova

People’s Friendship University of Russia (RUDN University)

Email: izhirov@mail.ru
ORCID iD: 0000-0003-0724-6508

Graduate Student, People’s Friendship University of Russia (RUDN University)

Russian Federation, Moscow

Yulia F. Osmolovskaya

Chazov National Medical Research Center of Cardiology

Email: izhirov@mail.ru
ORCID iD: 0000-0002-7827-2618

Cand. Sci. (Med.), Chazov National Medical Research Center of Cardiology

Russian Federation, Moscow

Irina A. Zhirova

People’s Friendship University of Russia (RUDN University)

Email: izhirov@mail.ru
ORCID iD: 0000-0002-6621-2052

Cand. Sci. (Med.), People’s Friendship University of Russia (RUDN University)

Russian Federation, Moscow

Rinat R. Gimadiev

People’s Friendship University of Russia (RUDN University)

Email: izhirov@mail.ru
ORCID iD: 0000-0002-9567-3317

Assistant of Professor, People’s Friendship University of Russia (RUDN University)

Russian Federation, Moscow

Olga Ia. Chaikovskaia

Chazov National Medical Research Center of Cardiology

Email: izhirov@mail.ru
ORCID iD: 0000-0002-2251-1675

Clinical Resident, Chazov National Medical Research Center of Cardiology

Russian Federation, Moscow

Oleg M. Reitblat

Regional Clinical Hospital №1

Email: izhirov@mail.ru
ORCID iD: 0000-0002-9407-5497

Cand. Sci. (Med.), Regional Clinical Hospital №1

Russian Federation, Tyumen

Iuliia Sh. Prints

Regional Clinical Hospital №1

Email: izhirov@mail.ru
ORCID iD: 0000-0001-8331-6307

Head of Cardiology Department, Regional Clinical Hospital №1

Russian Federation, Tyumen

Anatoly G. Kochetov

Pirogov Russian National Research Medical University

Email: izhirov@mail.ru
ORCID iD: 0000-0003-3632-291X

D. Sci. (Med.), Pirogov Russian National Research Medical University

Russian Federation, Moscow

Sergey N. Tereshchenko

Chazov National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

Email: tereschenko@yandex.ru
ORCID iD: 0000-0001-9234-6129

D. Sci. (Med.), Prof., Chazov National Medical Research Center of Cardiology, Russian Medical Academy of Continuous Professional Education

Russian Federation, Moscow; Moscow

References

  1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021:ehab368.
  2. Терещенко С.Н., Галявич А.С., Ускач Т.М., и др. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083 [Tereshchenko SN, Galyavich AS, Uskach TM, et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083 (in Russian)].
  3. Терещенко С.Н., Жиров И.В., Ускач Т.М., и др. Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/ Национальное общество специалистов по заболеваниям миокарда и сердечной недостаточности (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2020). Евразийский кардиологический журнал. 2020;3:6-76 [Tereshchenko SN, Zhirov IV, Uskach TM, et al. Eurasian association of cardiology (EAC)/National society of heart failure and myocardial disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2020). Eurasian Heart Journal. 2020;3:6-76 (in Russian)].
  4. Ponikowski P, Voors A, Anker S, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200.
  5. Жиров И.В., Насонова С.Н., Халилова У.А., и др. Острая сердечная недостаточность: классификация, диагностика, общие подходы к лечению. Consilium Medicum. 2021;23(10):750-5 [Zhirov IV, Nasonova SN, Khalilova UA, et al. Acute heart failure: classification, diagnosis, general approaches to treatment. Consilium Medicum. 2021;23(10):750-5 (in Russian)].
  6. Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715-31.
  7. Lichtenstein D, Axler O. Intensive use of general ultrasound in the intensive care unit (a prospective study of 150 consecutive patients). Intensive Care Med. 1993;19:353-5.
  8. Lichtenstein D. L’échographie générale en réanimation. 1st ed. Paris: Springer, 1992.
  9. Picano E, Scali M, Ciampi Q, et al. Lung Ultrasound for the Cardiologist. JACC: Cardiovasc Imaging. 2018;11(11):1692-705.
  10. Monti Z, Coppola S, Agricola V, et al. Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol. 2004;93:1265-70.
  11. Volpicelli G, Elbarbary M, Blaivas M, et al. International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012;38:577.
  12. Khosla R. Bedside Lung Ultrasound in Emergency (BLUE) Protocol: a suggestion to modify. Chest. 2010;137(6):1487-93.
  13. Жиров И.В., Терещенко С.Н., Павленко Т.А. Использование ультразвукового исследования легких для оценки декомпенсации сердечной недостаточности и необходимости коррекции диуретической терапии. Неотложная кардиология. 2019;2:24-34 [Zhirov IV, Tereshchenko SN, Pavlenko TA. Usage of lung ultrasound for diagnostics of heart failure decompensation and control of diuretic therapy. Emergency Cardiology. 2019;2:24-34 (in Russian)].
  14. Rappaport D. Noninvasive monitoring of pulmonary congestion using a remote dielectric sensing (ReDS) system: a prospective single-arm study in patients suffering from heart failure. J Card Fail. 2012;18(Suppl. 8):S61.
  15. Bensimhon D. The use of the reds noninvasive lung fluid monitoring system to assess readiness for discharge in patients hospitalized with acute heart failure: A pilot study. Heart Lung. 2021;50(1):59-64.
  16. Бойцов С.А., Терещенко С.Н., Жиров И.В., Агеев Ф.Т. Совершенствование оказания медицинской помощи больным с хронической сердечной недостаточностью. Методические рекомендации. М.: ФГБУ «НМИЦ кардиологии», 2020 [Boitsov SA, Tereshchenko SN, Zhirov IV, Ageev FT. Sovershenstvovanie okazaniia meditsinskoi pomoshchi bol'nym s khronicheskoi serdechnoi nedostatochnost'iu. Metodicheskie rekomendatsii. M.: FGBU "NMITs kardiologii", 2020 (in Russian)].
  17. Терещенко С.Н., Еременко А.А., Жиров И.В. Острая сердечная недостаточность. Интенсивная терапия. Национальное руководство. Под ред. И.Б. Заболотских, Д.Н. Проценко. М.: ГЭОТАР-Медиа, 2020. Т. 1; с. 1063-85 [Tereshchenko SN, Eremenko AA, Zhirov IV. Ostraia serdechnaia nedostatochnost'. Intensivnaia terapiia. Natsional'noe rukovodstvo. Pod red. IB Zabolotskih, DN Procenko. Moscow: GEOTAR-Media, 2020. T. 1; s.1063-85 (in Russian)].
  18. Арутюнов Г.П., Лопатин Ю.М., Аметов А.С., и др. Эмпаглифлозин и сердечная недостаточность: согласованное мнение экспертов по результатам онлайн-совещания и обсуждения исследования EMPEROR-Preserved. Терапевтический архив. 2021;93(12):1491-7 [Arutyunov GP, Lopatin YuM, Ametov AS, et al. Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(12):1491-7 (in Russian)].
  19. Velazquez EJ, Morrow DA, DeVore AD, et al. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019;380:539-48.
  20. Tromp J, Ponikowski P, Salsali A, et al. Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial. Eur J Heart Fail. 2021;23:826-34.
  21. Maddox TM, Januzzi JL, Allen LA, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction. J Am Coll Cardiol. 2021;77(6):772-810.
  22. Ponikowski P, Kirwan B, Anker S, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396:1895-904.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1

Download (258KB)
Indexing metadata
3. Fig. 2

Download (224KB)
Indexing metadata

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies